Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) Short Interest Update

Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) was the target of a significant growth in short interest in the month of August. As of August 14th, there was short interest totaling 23,657 shares, a growth of 1,351.3% from the July 30th total of 1,630 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley upgraded shares of Towa Pharmaceutical to an “overweight” rating in a report on Friday, June 12th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, Towa Pharmaceutical presently has a consensus rating of “Buy”.

Towa Pharmaceutical Stock Performance

Shares of TWAPF remained flat at $25.98 during midday trading on Tuesday. Towa Pharmaceutical has a 1-year low of $25.71 and a 1-year high of $26.00. The stock has a 50-day moving average of $25.80 and a 200-day moving average of $25.50.

Institutional Investors Weigh In On Towa Pharmaceutical

An institutional investor recently bought a new stake in Towa Pharmaceutical stock. Public Employees Retirement System of Ohio purchased a new position in Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 96,968 shares of the company’s stock, valued at approximately $3,285,000.

Towa Pharmaceutical Company Profile

Towa Pharmaceutical Co, Ltd. (OTCMKTS:TWAPF) is a Japan-based healthcare company primarily engaged in the research, development, manufacturing and sale of pharmaceutical products. The company’s product portfolio spans active pharmaceutical ingredients (APIs), finished dosage forms such as tablets and capsules, and over-the-counter (OTC) preparations. Towa Pharmaceutical serves both prescription and consumer healthcare markets, offering formulations that address chronic conditions, lifestyle-related illnesses and general wellness.

In addition to its in-house product lines, Towa Pharmaceutical provides contract manufacturing and development services to domestic and international partners.